Research

Cray Diabetes Management Center is seeking patients with Type 2 Diabetes to participate in a research study evaluating the safety and effectiveness of an investigational diabetes medication that will be administered once a week, once every two weeks, or once every four weeks, depending on which group they are assigned to. To be eligible you must be between 18 and 75 years, diagnosed with type 2 diabetes, receiving treatment for your diabetes either Metformin (Glucophage) only or diet and exercise program with no medication.

Qualified participants will receive study-related medical evaluations and study medication at no cost. Research participants will be compensated $20 for every visit they complete. If you would like to learn more about this study please contact Debbie Lee at 913-588-3960, or by e-mail at dlee@kumc.edu

top of page

Endocrine, Metabolism
& Genetics
University of Kansas
Medical Center
4023 Wescoe Pavilion
Mail Stop 2024
3901 Rainbow Boulevard
Kansas City, KS 66160
Phone: (913) 588-6022
Fax Number: (913) 588-4060

© The University of Kansas Medical Center
About this Site | An EO/AA/Title IX Institution | Privacy Statement | Site Index | Help
The University of Kansas Medical Center prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University's programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Executive Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1054 Wescoe, 3901 Rainbow Blvd,. K.C., KS 66160, 913-588-5048.